Zobrazeno 1 - 10
of 837
pro vyhledávání: '"Robert M, Grant"'
Autor:
Vivian I. Avelino-Silva, Mars Stone, Sonia Bakkour, Clara Di Germanio, Michael Schmidt, Ashtyn L. Conway, David Wright, Eduard Grebe, Brian Custer, Steven H. Kleinman, Xutao Deng, Jairam R. Lingappa, Patricia Defechereux, Megha Mehrotra, Robert M. Grant, Sandhya Vasan, Shelley Facente, Nittaya Phanuphak, Carlo Sacdalan, Siriwat Akapirat, Mark de Souza, Michael P. Busch, Philip J. Norris
Publikováno v:
International Journal of Infectious Diseases, Vol 148, Iss , Pp 107222- (2024)
Background: Exposure to antiretrovirals at or early after HIV acquisition can suppress viral replication and blunt antibody (Ab) responses; a reduced HIV detectability could impact diagnosis and blood donation screening. Methods: We used three antige
Externí odkaz:
https://doaj.org/article/92fa30bdd04e4470a37e6d61700db99e
Publikováno v:
Journal of Medical Internet Research, Vol 23, Iss 7, p e22650 (2021)
BackgroundHIV pre-exposure prophylaxis (PrEP) is a way to prevent HIV infection using antiretroviral medications. However, common barriers to PrEP engagement include lack of access to prescribers; discomfort seeking sexual health services; and racism
Externí odkaz:
https://doaj.org/article/cde6cde66b5c40c19fc6f7b42ed80a9b
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 19 (2020)
In the United States, uptake of daily oral pre-exposure prophylaxis (PrEP) to prevent HIV continues to grow albeit at a slower than desired pace. Innovations in PrEP delivery systems may partially address structural challenges related to PrEP uptake
Externí odkaz:
https://doaj.org/article/255ac17379e041ae8785ace3efd8ef26
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0213167 (2019)
BackgroundEarly initiation of antiretroviral therapy (eiART) can improve clinical outcomes for persons with HIV and reduce onward transmission risk. Baseline drug resistance testing (bDRT) can inform regimen selection upon subsequent treatment initia
Externí odkaz:
https://doaj.org/article/7ea9fb5787b44901b8499d4385460a38
Autor:
Robert M. Grant
Publikováno v:
Integral Psychedelic Therapy ISBN: 9781003167976
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18937a9bc7554f20ad28463262774bdc
https://doi.org/10.4324/9781003167976-11
https://doi.org/10.4324/9781003167976-11
Autor:
Kimberly A. Koester, Xavier A. Erguera, Mi-Suk Kang Dufour, Ifeoma Udoh, Jeffrey H. Burack, Robert M. Grant, Janet J. Myers
Publikováno v:
Frontiers in Public Health, Vol 6 (2018)
The use of HIV serostatus information has played a pivotal role in partner selection norms. A phenomenon known as serosorting is the practice of selecting a partner based on a perception that they are of the same HIV status in order to avoid transmis
Externí odkaz:
https://doaj.org/article/38726d501bd944aab184100c36648734
Autor:
Kathleen E. Ryan, Anne Mak, Mark Stoove, Brian Price, Christopher K. Fairley, Simon Ruth, Luxshimi Lal, Jason Asselin, Carol El-Hayek, Long Nguyen, Colin Batrouney, David Wilson, John Lockwood, Dean Murphy, Vincent J. Cornelisse, Norman Roth, Jeff Willcox, Christina C. Chang, Judy Armishaw, Ban K. Tee, Matthew Penn, George Forgan-Smith, Christopher Williams, Jeff Montgomery, Kat Byron, Alison Coelho, Brent Allen, Jeremy Wiggins, Jenny Kelsall, Olga Vujovic, Michael West, Anna B. Pierce, Daniel Gallant, Charlotte Bell, John B. F. de Wit, Jennifer F. Hoy, Steve L. Wesselingh, Robert M. Grant, Edwina J. Wright
Publikováno v:
Frontiers in Public Health, Vol 6 (2018)
Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV transmission in people at high risk of HIV acquisition. PrEP is highly efficacious when taken either daily, or in an on-demand schedule. In Australia
Externí odkaz:
https://doaj.org/article/99a750e5549a44888f72a8203fde0c2a
Autor:
Dominique B Figueroa, Joseph Tillotson, Maoji Li, Estelle Piwowar-Manning, Craig W Hendrix, Timothy H Holtz, Kevin Bokoch, Linda-Gail Bekker, Frits van Griensven, Sharon Mannheimer, James P Hughes, Robert M Grant, Namandjé N Bumpus
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195764 (2018)
Tenofovir (TFV), a nucleotide reverse transcriptase inhibitor, requires two phosphorylation steps to form a competitive inhibitor of HIV reverse transcriptase. Adenylate kinase 2 (AK2) has been previously demonstrated to phosphorylate tenofovir to te
Externí odkaz:
https://doaj.org/article/5c4afdf43275489faacaf0ba13a21d5d
Autor:
Anupama Phene, Robert M. Grant
Publikováno v:
Global Strategy Journal. 12:3-30
The centrality of knowledge to the global arena has allowed scholars in this area to play a leading role in developing the knowledge-based view (KBV) of the firm. Although the KBV has developed as a view rather than a self-standing theory of the mult
Autor:
Joss J De Wet, Amanda Clarke, Karam Mounzer, Lijie Zhong, Moupali Das, Frank A. Post, Diana M. Brainard, Heiko Jessen, Edwin DeJesus, Sean E Collins, Anita Mathias, Pamela Wong, C. Bradley Hare, Pep Coll, Cynthia Brinson, Scott McCallister, Kenneth H. Mayer, Christian Callebaut, Peter Ruane, Robert M. Grant, Ramin Ebrahimi, Melanie A. Thompson, Jean-Michel Molina, Peter L. Anderson
Publikováno v:
The Lancet. 396:239-254
Summary Background Tenofovir alafenamide shows high antiviral efficacy and improved renal and bone safety compared with tenofovir disoproxil fumarate when used for HIV treatment. Here, we report primary results from a blinded phase 3 study evaluating